Regulation Proposal for E-Cigarettes with Synthetic Nicotine Causes Controversy

Regulations by 2FIRSTS.ai
Nov.22.2023
Regulation Proposal for E-Cigarettes with Synthetic Nicotine Causes Controversy
South Korea's proposed regulation to subject e-cigarettes made with synthetic nicotine to tobacco laws faces opposition.

According to news from the South Korean National Assembly on the 22nd, a proposal that synthetic nicotine, used as a raw material for e-cigarettes, should be regulated under the Tobacco Business Act as regular tobacco, despite opposition from the Ministry of Strategy and Finance, might be abandoned. The National Assembly's Finance Committee held an economic and financial subcommittee meeting on the 21st and expanded the range of tobacco raw materials, including natural nicotine such as stems and roots, which were previously excluded. Additionally, synthetic nicotine made from chemicals was excluded. They plan to meet again on the 23rd to confirm these details.

 

The South Korean Ministry of Finance has stated that while they agree to address the gaps in tobacco regulation, they cannot give their consent to a proposed bill recognizing synthetic nicotine, which has not yet been verified for toxicity, safety, and other factors, as tobacco.

 

The majority of e-cigarettes available on the market are made using synthetic nicotine. According to the Health Promotion Development Research Institute of South Korea, 92.2% of e-cigarettes sold online use synthetic nicotine. The import volume of synthetic nicotine oil has been increasing every year. According to data from the Korean Customs, it went from 56 tons in 2020 to 119 tons last year. In just the first half of this year, 91 tons have already been imported, and it is estimated to reach almost 200 tons by the end of the year.

 

However, unlike natural nicotine, synthetic nicotine is not subject to tax. This is because current tobacco industry laws define tobacco as being derived from tobacco leaves. The total import value of synthetic nicotine oil last year was $7.299 million, but there were no domestic taxes levied on it. According to information submitted to Congress by the e-cigarette association, as of 2019, over 4,300 e-cigarette shops nationwide achieved sales of 1.4746 trillion Korean won (approximately $1.13 billion). However, unlike traditional cigarettes, it is not subject to taxation.

 

In the past, the government imposed taxes on products made from tobacco leaves. However, starting from 2021, taxes have also been extended to naturally extracted nicotine from stems and roots through amendments to the Personal Consumption Tax Law and Local Tax Law. The taxes levied include tobacco consumption tax, local education tax, personal consumption tax, and national health promotion burden, amounting to 1,799 Korean won (approximately $1.4) per liter. This is driven by the rapid growth of the e-cigarette market using synthetic nicotine as a raw material.

 

Due to the lack of legal regulation, e-cigarettes can simply be purchased online by verifying that the buyer is of legal age. Unlike the restrictions in place for online sales of cigarettes or alcohol to limit adolescent exposure, e-cigarettes currently exist in a legal gray area.

 

Due to this situation, it has been pointed out that e-cigarettes are increasing the smoking rates among teenagers. In fact, the smoking rate among adults has decreased from 66.3% in 1998 to 34.0% in 2020, but e-cigarette use has risen from 1.1% in 2013 to 2.3% last year. Particularly alarming is the increase in e-cigarette use among adolescents, with rates for boys rising from 3.7% in 2021 to 4.5% last year, and for girls increasing from 1.9% to 2.2%. These figures highlight a growing trend.

 

The reasons why teenagers opt to purchase these products include their light scent, convenience in purchasing, and diverse designs. Due to the various appealing flavors available, they can be easily consumed indoors, allowing teenagers to avoid adult scrutiny, as the smell is minimal.

 

However, as pointed out by the Ministry of Finance, the controversy over the harmfulness of synthetic nicotine has yet to be resolved. Last month, with the passage of the Tobacco Harmful Management Act in Congress, tobacco companies will be required to disclose their ingredients every two years starting from November 2025. However, even synthetic nicotine has been excluded from this requirement. Therefore, there have been suggestions that a taxation system based on nicotine content should be established alongside the public disclosure of synthetic nicotine ingredients.

 

Tobacco industry insiders have expressed concerns over the legal loopholes that small-scale importers of synthetic nicotine are currently navigating. While traditional tobacco businesses are considering or reviewing the use of natural nicotine in liquid e-cigarettes, these importers are facing challenges. The need to disclose the composition of synthetic nicotine and streamline the taxation system has been highlighted as necessary.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11